Skip to content
Lower risk Drug recall · FDA · Published August 25, 2026

Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles

Ajanta Pharma recalls 100-count Fluphenazine Hydrochloride tablets due to impurity levels exceeding safety limits. Affected lots have specific expiration dates and are prescription-only.

🇺🇸 FDA recall #D-0836-2026DrugAjanta Pharma ›
✎ GovInfoNow plain-language explainer

Ajanta Pharma is recalling 100-count Fluphenazine Hydrochloride tablets (1mg) that tested with higher impurity levels than allowed. This could pose a risk to patients taking the medication. Read more at govinfonow.com/recall/1004686-ajanta-pharma-fluphenazine-tablets-recall-impurity-risk-in-100-count.

Source Summary by GovInfoNow · govinfonow.com/recall/1004686-ajanta-pharma-fluphenazine-tablets-recall-impurity-risk-in-100-count · Updated September 23, 2026 · FDA enforcement record: FDA #D-0836-2026

Cite this page

“Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004686-ajanta-pharma-fluphenazine-tablets-recall-impurity-risk-in-100-count. Based on FDA recall #D-0836-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0836-2026%22&limit=1).

The FDA announced on August 25, 2026, that Ajanta Pharma USA Inc. is recalling Fluphenazine Hydrochloride Tablets, USP, 1mg, due to failed impurity specifications. The agency issued recall number D-0836-2026 for the voluntary Class III action.

How to tell if you have it

  • Brand: Ajanta Pharma
  • Product: Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles
  • NDC: 27241-255-01
  • Lot codes: DJ23254 (Exp. Date 11/30/2026), DJ10205 (Exp. Date 04/30/2027)
  • Quantity: 403,200 tablets

The hazard

The tablets failed impurity specifications because Organic Impurities by HPLC (Impurity-A) tested at 1.1 percent during 18-month long-term stability testing, exceeding the 1.0 percent specification limit according to the FDA.

Context

GovInfoNow's records show Ajanta Pharma USA Inc. has two other recalls on record since May 27, 2026, including a May 28, 2026 recall of Fenofibrate Capsules for CGMP deviations and a May 27, 2026 recall of Aripiprazole Tablets due to a mix-up with Voriconazole. Other recent recalls of similar products include an April 29, 2026 recall of Duloxetine capsules due to potential impurity risk and a June 1, 2026 recall of Sun Pharmaceutical Fexofenadine 180mg Tablets for impurities.

How to tell if you have this one

Check for the product name 'Fluphenazine Hydrochloride Tablets, USP, 1mg, 100-count bottles' with lot numbers DJ23254 (expiring 11/30/2026) or DJ10205 (expiring 04/30/2027).

  • Brand
    Ajanta Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the bottle to see if it matches the recalled lots.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide within the U.S” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 22 days after the firm started it.

1. Firm started the recall: Aug 25, 202612. FDA classified it Class III: Sep 8, 202623. Published in FDA’s Enforcement Report: Sep 16, 202634. Added to GovInfoNow: Sep 23, 202642026
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Ajanta Pharma recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0836-2026 (August 25, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0836-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA